[ad_1]
SÃO PAULO, SP (FOLHAPRESS) – A Datafolha survey has proven what doctors already see every day: the Brazilian knows very little about diabetes.
Asked about their knowledge of the disease, in a spontaneous response, only 10% of those surveyed mentioned that it could cause death, 7% said that it could cause blindness and 7% stated that the disease was not healing. Yet, complications were the most cited item, for a total of 28% of people.
The symptoms are in a second group of mentions (24%), followed by treatment (19%) and diet (18%).
Only 15% spontaneously mentioned that diabetes causes an increase in blood sugar and 16% that the person with diabetes can not eat sugar. Only 2% reported cardiovascular disease, the leading cause of death in people with diabetes.
The survey was conducted among the general population aged 16 and over, between May 12 and 19, 2018, in 153 municipalities. The maximum margin of error for the total sample is 2 percentage points plus or minus.
"Unfortunately, we are not surprised by the results." The condition of the patient with diabetes in the country is low, one in two people with diabetes do not know that she has the disease. There are many complications: the development of diabetes is treacherously silent, "says Hermelinda Pedrosa, president of the Brazilian Diabetes Society.
"People need to know that physical activity, good nutrition and the fight against diseases like hypertension and high cholesterol can help prevent diabetes."
The research was commissioned by a coalition of pharmacists, NGOs, and medical societies that together launched the Movement to survive on Tuesday (24) at 8:30 pm in Rio.
At this time, symbols of unhealthy habits that could lead to type 2 diabetes will be projected on Christ the Redeemer, to show that, for lack of adequate care, the disease increases the risk of developing diabetes. myocardial infarction.
Participants include the Brazilian Diabetes Association (ADJ), the National Association of Diabetes Care (ANAD), the Side by Side Institute, the Brazilian Stroke Network, the Brazilian Society of Cardiology (SBC), the Brazilian Diabetes Society SBD) and the pharmaceutical companies Boehringer Ingelheim and Eli Lilly do Brasil.
The coalition was created to promote a reflection on the provision of modern medicines for elderly people with diabetes and cardiovascular disease, with the aim of reducing deaths and avoiding high treatment costs for the elderly. # 39; State.
Pedrosa states that the more modern drugs are more expensive than the three classes now proposed by SUS, but that their cost-benefit needs to be evaluated in a broad discussion with health managers, medical societies and patient associations
[ad_2]
Source link
